Intravascular Ultrasound for Hepatocellular Carcinoma Staging
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00474734 |
Recruitment Status
: Unknown
Verified May 2007 by University Hospital, Geneva.
Recruitment status was: Recruiting
First Posted
: May 17, 2007
Last Update Posted
: May 17, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.
Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential.
As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.
Condition or disease | Intervention/treatment |
---|---|
Hepatocellular Carcinoma | Device: Intravascular ultrasound of the liver |
Study Type : | Observational |
Observational Model: | Defined Population |
Primary Purpose: | Screening |
Time Perspective: | Longitudinal |
Time Perspective: | Prospective |
Official Title: | Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study |
Study Start Date : | May 2007 |
Estimated Study Completion Date : | September 2007 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- hepatocellular carcinoma nodules
- patient on liver transplantation waiting list
- written informed consent
Exclusion Criteria:
- thrombosis of hepatic veins or vena cava

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00474734
Contact: Antoine Hadengue, Prof. | +41 22 37 29 340 | antoine.hadengue@hcuge.ch |
Switzerland | |
University Hospital Geneva | Recruiting |
Geneva, Switzerland | |
Contact: Andrea De Gottardi, MD PhD +41 22 37 29 256 andrea.degottardi@hcuge.ch |
Study Chair: | Antoine Hadengue, Prof. | University Hospital, Geneva |
ClinicalTrials.gov Identifier: | NCT00474734 History of Changes |
Obsolete Identifiers: | NCT00472979 |
Other Study ID Numbers: |
07-063 |
First Posted: | May 17, 2007 Key Record Dates |
Last Update Posted: | May 17, 2007 |
Last Verified: | May 2007 |
Keywords provided by University Hospital, Geneva:
hepatocellular carcinoma liver transplantation staging intravascular ultrasound |
Additional relevant MeSH terms:
Carcinoma Carcinoma, Hepatocellular Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Adenocarcinoma |
Liver Neoplasms Digestive System Neoplasms Neoplasms by Site Digestive System Diseases Liver Diseases |